Sponsor:
Ardelyx
Code:
NCT07382167
Conditions
Chronic Idiopathic Constipation (CIC)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Tenapanor 5 mg BID
Tenapanor 25 mg BID
Tenapanor 50 mg BID
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-05. This information was provided to ClinicalTrials.gov by Ardelyx on 2026-02-02.